Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amn Healthcare Services (AMN) EBITDA (2016 - 2025)

Amn Healthcare Services (AMN) has disclosed EBITDA for 16 consecutive years, with -$7.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 95.91% year-over-year to -$7.7 million, compared with a TTM value of -$95.4 million through Dec 2025, up 34.92%, and an annual FY2025 reading of -$95.4 million, up 34.92% over the prior year.
  • EBITDA was -$7.7 million for Q4 2025 at Amn Healthcare Services, down from $29.4 million in the prior quarter.
  • Across five years, EBITDA topped out at $145.1 million in Q1 2022 and bottomed at -$187.5 million in Q4 2024.
  • Average EBITDA over 5 years is $37.0 million, with a median of $57.1 million recorded in 2023.
  • The sharpest move saw EBITDA skyrocketed 1144.14% in 2021, then crashed 1579.08% in 2024.
  • Year by year, EBITDA stood at $115.9 million in 2021, then decreased by 29.29% to $81.9 million in 2022, then plummeted by 84.53% to $12.7 million in 2023, then plummeted by 1579.08% to -$187.5 million in 2024, then skyrocketed by 95.91% to -$7.7 million in 2025.
  • Business Quant data shows EBITDA for AMN at -$7.7 million in Q4 2025, $29.4 million in Q3 2025, and -$116.1 million in Q2 2025.